$NOTV
Inotiv, Inc.

2017 Q3 Form 10-Q Financial Statement

#000114420417043033 Filed on August 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2017 Q2 2016 Q2
Revenue $5.870M $5.836M $5.053M
YoY Change 13.98% 15.5% -17.84%
Cost Of Revenue $4.010M $3.905M $3.880M
YoY Change -4.52% 0.64% 6.01%
Gross Profit $1.860M $1.931M $1.173M
YoY Change 95.79% 64.62% -52.89%
Gross Profit Margin 31.69% 33.09% 23.21%
Selling, General & Admin $1.450M $1.467M $1.435M
YoY Change -17.61% 2.23% 1.34%
% of Gross Profit 77.96% 75.97% 122.34%
Research & Development $130.0K $127.0K $103.0K
YoY Change 30.0% 23.3% -35.63%
% of Gross Profit 6.99% 6.58% 8.78%
Depreciation & Amortization $380.0K $440.0K $360.0K
YoY Change -28.3% 22.22% 5.88%
% of Gross Profit 20.43% 22.79% 30.69%
Operating Expenses $1.570M $1.594M $1.538M
YoY Change -16.04% 3.64% 60.88%
Operating Profit $290.0K $337.0K -$365.0K
YoY Change -131.52% -192.33% -123.79%
Interest Expense -$50.00K $112.0K $107.0K
YoY Change -68.75% 4.67% 59.7%
% of Operating Profit -17.24% 33.23%
Other Income/Expense, Net $0.00 $2.000K $1.000K
YoY Change 100.0%
Pretax Income $240.0K $227.0K -$450.0K
YoY Change -111.76% -150.44% -129.98%
Income Tax $10.00K $6.000K -$17.00K
% Of Pretax Income 4.17% 2.64%
Net Earnings $230.0K $221.0K -$433.0K
YoY Change -111.27% -151.04% -129.3%
Net Earnings / Revenue 3.92% 3.79% -8.57%
Basic Earnings Per Share $0.03 -$0.05
Diluted Earnings Per Share $26.23K $0.03 -$0.05
COMMON SHARES
Basic Shares Outstanding 8.239M shares 8.216M shares 8.108M shares
Diluted Shares Outstanding 8.748M shares 8.108M shares

Balance Sheet

Concept 2017 Q3 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $430.0K $920.0K $490.0K
YoY Change 10.26% 87.76% -5.77%
Cash & Equivalents $434.0K $919.0K $492.0K
Short-Term Investments
Other Short-Term Assets $810.0K $600.0K $820.0K
YoY Change 1.25% -26.83% 49.09%
Inventory $913.0K $1.060M $1.480M
Prepaid Expenses $814.0K
Receivables $2.530M $2.060M $2.500M
Other Receivables $620.0K $410.0K $1.030M
Total Short-Term Assets $5.306M $5.050M $6.310M
YoY Change 8.8% -19.97% -5.45%
LONG-TERM ASSETS
Property, Plant & Equipment $14.97M $15.21M $16.09M
YoY Change -7.26% -5.47% 3.5%
Goodwill $38.00K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $21.00K $20.00K $100.0K
YoY Change -22.22% -80.0% 194.12%
Total Long-Term Assets $15.11M $15.35M $17.20M
YoY Change -7.02% -10.76% 3.06%
TOTAL ASSETS
Total Short-Term Assets $5.306M $5.050M $6.310M
Total Long-Term Assets $15.11M $15.35M $17.20M
Total Assets $20.42M $20.40M $23.51M
YoY Change -3.37% -13.23% 0.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.052M $1.660M $3.950M
YoY Change -30.79% -57.97% 61.49%
Accrued Expenses $1.202M $1.190M $820.0K
YoY Change 10.38% 45.12% -23.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $260.0K $1.550M
YoY Change -100.0% -83.23%
Long-Term Debt Due $224.0K $224.0K $3.863M
YoY Change -93.87% -94.2% 391.48%
Total Short-Term Liabilities $7.723M $7.859M $13.81M
YoY Change -42.68% -43.1% 74.1%
LONG-TERM LIABILITIES
Long-Term Debt $4.158M $4.208M $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.158M $4.208M $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.723M $7.859M $13.81M
Total Long-Term Liabilities $4.158M $4.208M $0.00
Total Liabilities $11.95M $12.17M $14.04M
YoY Change -12.59% -13.35% 17.69%
SHAREHOLDERS EQUITY
Retained Earnings -$16.04M -$16.27M -$14.89M
YoY Change -5.22% 9.28% 14.69%
Common Stock $2.023M $2.021M $1.989M
YoY Change 1.71% 1.61% 0.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.467M $8.227M $9.471M
YoY Change
Total Liabilities & Shareholders Equity $20.42M $20.40M $23.51M
YoY Change -3.37% -13.26% 0.64%

Cashflow Statement

Concept 2017 Q3 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $230.0K $221.0K -$433.0K
YoY Change -111.27% -151.04% -129.3%
Depreciation, Depletion And Amortization $380.0K $440.0K $360.0K
YoY Change -28.3% 22.22% 5.88%
Cash From Operating Activities -$10.00K $690.0K $140.0K
YoY Change -101.27% 392.86% -81.08%
INVESTING ACTIVITIES
Capital Expenditures -$140.0K -$50.00K -$210.0K
YoY Change -66.67% -76.19% -52.27%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$130.0K -$60.00K -$210.0K
YoY Change -69.05% -71.43% -52.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -340.0K -130.0K 100.0K
YoY Change -29.17% -230.0% -138.46%
NET CHANGE
Cash From Operating Activities -10.00K 690.0K 140.0K
Cash From Investing Activities -130.0K -60.00K -210.0K
Cash From Financing Activities -340.0K -130.0K 100.0K
Net Change In Cash -480.0K 500.0K 30.00K
YoY Change 336.36% 1566.67% -25.0%
FREE CASH FLOW
Cash From Operating Activities -$10.00K $690.0K $140.0K
Capital Expenditures -$140.0K -$50.00K -$210.0K
Free Cash Flow $130.0K $740.0K $350.0K
YoY Change -89.26% 111.43% -70.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7859000 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13473000 USD
CY2017Q2 us-gaap Liabilities
Liabilities
12168000 USD
CY2016Q3 us-gaap Liabilities
Liabilities
13671000 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
2021000 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
1989000 USD
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21437000 USD
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21240000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16266000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16921000 USD
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
8227000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
7458000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20395000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21129000 USD
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
1035000 USD
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
1185000 USD
CY2017Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2016Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
35000 USD
CY2017Q2 us-gaap Lease Incentive Receivable Noncurrent
LeaseIncentiveReceivableNoncurrent
78000 USD
CY2016Q3 us-gaap Lease Incentive Receivable Noncurrent
LeaseIncentiveReceivableNoncurrent
51000 USD
CY2017Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1117000 USD
CY2016Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1117000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8720000 shares
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
15180000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
11881000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3189000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3406000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
18369000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
15287000 USD
us-gaap Cost Of Services
CostOfServices
10604000 USD
us-gaap Cost Of Services
CostOfServices
9838000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1932000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1976000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12536000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11814000 USD
us-gaap Gross Profit
GrossProfit
5833000 USD
us-gaap Gross Profit
GrossProfit
3473000 USD
us-gaap Selling Expense
SellingExpense
808000 USD
us-gaap Selling Expense
SellingExpense
1072000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
340000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
392000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3699000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3165000 USD
us-gaap Operating Expenses
OperatingExpenses
4847000 USD
us-gaap Operating Expenses
OperatingExpenses
4629000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
986000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1156000 USD
us-gaap Interest Expense
InterestExpense
322000 USD
us-gaap Interest Expense
InterestExpense
243000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-189000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
668000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1208000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15000 USD
us-gaap Net Income Loss
NetIncomeLoss
655000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1193000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
690000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1294000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8157000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8107000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8107000 shares
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-35000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
101000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 USD
CY2017Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4954000 USD
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
3773000 USD
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
882000 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1280000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
5836000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
5053000 USD
CY2017Q2 us-gaap Cost Of Services
CostOfServices
3308000 USD
CY2016Q2 us-gaap Cost Of Services
CostOfServices
3183000 USD
CY2017Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
597000 USD
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
697000 USD
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3905000 USD
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3880000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-6000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
2000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1303000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1031000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
13000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
34000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
9000 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
1931000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
1173000 USD
CY2017Q2 us-gaap Selling Expense
SellingExpense
229000 USD
CY2016Q2 us-gaap Selling Expense
SellingExpense
405000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
127000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
103000 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1238000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1030000 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
1594000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
1538000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
337000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-365000 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
112000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
107000 USD
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-21000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
227000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-450000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
221000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-433000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
227000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-435000 USD
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8216000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8108000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8748000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8108000 shares
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-12000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-19000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
256000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-511000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-389000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
10000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-18000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-201000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1309000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
990000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
102000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-886000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
151000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-7000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1250000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
270000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
213000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
837000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-205000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-837000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3666000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
589000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
11166000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7832000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10064000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
9297000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
96000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
217000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-512000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
621000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
438000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
492000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
214000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
41000 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
533000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
54000 USD
CY2017Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
216000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
453000 USD
CY2017Q2 basi Share Based Compensation Options Outstanding Issued Outside Of Stock Option Plan
ShareBasedCompensationOptionsOutstandingIssuedOutsideOfStockOptionPlan
15000 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
655000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1193000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
655000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1193000 USD
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
555000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
221000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-433000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
221000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-433000 USD
CY2017Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
518000 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
14000 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2017Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
836000 USD
CY2016Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1190000 USD
CY2017Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
221000 USD
CY2016Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
267000 USD
CY2017Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
229000 USD
CY2017Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
222000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2017Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0195 pure
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Entity Registrant Name
EntityRegistrantName
BIOANALYTICAL SYSTEMS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000720154
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
BASI
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8238896 shares
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2293000 USD
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
565000 USD
CY2017Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
68000 USD
CY2016Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
10000 USD
CY2017Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2016Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
19000000 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
19000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8238896 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8238896 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8107558 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8107558 shares
CY2017Q2 us-gaap Revenues
Revenues
5836000 USD
CY2016Q2 us-gaap Revenues
Revenues
5053000 USD
us-gaap Revenues
Revenues
18369000 USD
us-gaap Revenues
Revenues
15287000 USD
CY2017Q2 us-gaap Inventory Gross
InventoryGross
1286000 USD
CY2016Q3 us-gaap Inventory Gross
InventoryGross
1741000 USD
us-gaap Other Restructuring Costs
OtherRestructuringCosts
117000 USD
us-gaap Interest Paid Net
InterestPaidNet
180000 USD
us-gaap Interest Paid Net
InterestPaidNet
196000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
150000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
303000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4500000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
66000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000 USD
CY2017Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
127000 USD
CY2016Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
126000 USD
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
224000 USD
CY2016Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3656000 USD
CY2017Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
101000 USD
CY2016Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
198000 USD
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4208000 USD
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67000 shares
basi Stock Issued During Period Stock Options Exercised Cashless
StockIssuedDuringPeriodStockOptionsExercisedCashless
17000 shares

Files In Submission

Name View Source Status
0001144204-17-043033-index-headers.html Edgar Link pending
0001144204-17-043033-index.html Edgar Link pending
0001144204-17-043033.txt Edgar Link pending
0001144204-17-043033-xbrl.zip Edgar Link pending
basi-20170630.xml Edgar Link completed
basi-20170630.xsd Edgar Link pending
basi-20170630_cal.xml Edgar Link unprocessable
basi-20170630_def.xml Edgar Link unprocessable
basi-20170630_lab.xml Edgar Link unprocessable
basi-20170630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v472752_10q.htm Edgar Link pending
v472752_ex10-1.htm Edgar Link pending
v472752_ex31-1.htm Edgar Link pending
v472752_ex31-2.htm Edgar Link pending
v472752_ex32-1.htm Edgar Link pending
v472752_ex32-2.htm Edgar Link pending